The report highlights Cumberland Pharmaceuticals' commitment to sustainability and transparency in its corporate operations. The company focuses on environmental, social, and governance (ESG) standards, including ethical drug production, community involvement, and fair pricing. The report also details the company's response to the COVID-19 pandemic, including safety measures implemented for employees and the continuation of product delivery and community support.
Issuing Company Cumberland Pharmaceuticals Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 3.89 MB
No. of Pages 16 pages
Reporting period2020
Report Edition1
Assurance Provider Unknown
Reporting Standards Unknown
Materiality Assessmenttrue